Mass Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.25 M
as on 03-12-2024
- Company Age 26 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue -15.21%
(FY 2021)
- Profit 127.20%
(FY 2021)
- Ebitda 144.75%
(FY 2021)
- Net Worth 1093.73%
(FY 2021)
- Total Assets 99.78%
(FY 2021)
About Mass Biomedicals
The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Snehashis Chakraborty and Mithu Chakraborty serve as directors at the Company.
- CIN/LLPIN
U99999DL1998PTC097004
- Company No.
097004
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 1998
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Mass Biomedicals Private Limited offer?
Mass Biomedicals Private Limited offers a wide range of products and services, including Blood Pressure Machine, Digital Blood Pressure Monitor.
Who are the key members and board of directors at Mass Biomedicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snehashis Chakraborty  | Director | 10-Nov-1998 | Current |
| Mithu Chakraborty | Director | 10-Nov-1998 | Current |
Financial Performance of Mass Biomedicals.
Mass Biomedicals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 15.21% decrease. The company also saw a substantial improvement in profitability, with a 127.2% increase in profit. The company's net worth Soared by an impressive increase of 1093.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mass Biomedicals?
In 2021, Mass Biomedicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Transmass Tm Biomedical Services India Private LimitedActive 9 years 4 monthsSnehashis Chakraborty is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mass Biomedicals?
Unlock and access historical data on people associated with Mass Biomedicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mass Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mass Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
